Khalil Qato

Khalil Qato

Auto-generated profile, based on publicly available information

Khalil Qato

Department of Surgery, Lenox Hill Hospital, Northwell Health, New York, NY, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
YEYana Etkin
Yana Etkin
ACAllan M. Conway
Allan M. Conway
JSJeffrey Silpe
Jeffrey Silpe
KQKhalil Qato
Khalil Qato
ACAlfio Carroccio
Alfio Carroccio
GLGregg S. Landis
Gregg S. Landis

30 July 2020 in Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PDF file
KQKhalil Qato
Khalil Qato
ACAllan Conway
Allan Conway
ELEileen Lu
Eileen Lu
NTNhan Nguyen Tran
Nhan Nguyen Tran
GGGary Giangola
Gary Giangola
ACAlfio Carroccio
Alfio Carroccio
Thoracic endovascular aortic repair (TEVAR) remains controversial in patients with connective tissue disorders given the concern for durability. We report on the largest series to date on outcomes of patients with thoracic aortic disease and connective tissue disorders treated with TEVAR. The Vascular Quality Initiative registry identified 12 207 patients treated with TEVAR from January 2010 to December 2018, including 102 with Marfans, Ehlers-Danlos, or Loey-Dietz syndrome. Outcomes were analyzed per the Society for Vascular Surgery reporting standards. Median age was 50.6 years (interquartile range: 57.0-75.0), and 62 (60.7%) were male. Eighty-eight (86.3%) patients had Marfan, 9 (8.8%) had Ehlers-Danlos, and 5 (4.9%) had Loey-Dietz syndrome. Twenty-six (25.5%) patients were treated for degenerative aneurysmal disease and 76 (74.5%) patients for type B dissections (33 acute, 31 chronic). Most common indications for interventions in patients with type B dissection were pain (n = 41), aneurysmal degeneration (n = 16), and malperfusion (n = 8), with 3 patients who presented ruptured. There was no significant difference in perioperative complications between acute/chronic dissections and aneurysms (P = .14). Percutaneous access was utilized in 61.7% of patients, with a 2.9% rate of arterial injury requiring reintervention. Follow-up data were available for 75 (73.3%) patients at a mean follow-up of 15.6 months. Overall mortality was 5.3%. There were 30 patients with follow-up endoleak data, and 8 (26.7%) endoleaks were identified. All endoleaks were in patients treated for acute type B dissection, and all resolved after a mean of 2.1 reinterventions. Three patients treated for acute Type B Aortic Dissection (TBAD) had retrograde dissections requiring intervention. Thoracic endovascular aortic repair for patients with connective tissue disorders can be performed with low perioperative mortality, spinal cord ischemia, or Cerebrovascular Accident (CVA). On follow-up, acute type B aortic dissections represent a higher risk subgroup with increased rates of endoleak and retrograde dissection. Closer follow-up for these patients and early reintervention may be beneficial.

1 September 2018 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
KQKhalil Qato
Khalil Qato
ACAllan M. Conway
Allan M. Conway
LMLaurie Mondry
Laurie Mondry
GGGary Giangola
Gary Giangola
ACAlfio Carroccio
Alfio Carroccio

23 July 2020 in Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PDF file
ACAllan M. Conway
Allan M. Conway
KQKhalil Qato
Khalil Qato
NTN. Nhan Nguyen Tran
N. Nhan Nguyen Tran
GGGary Giangola
Gary Giangola
ACAlfio Carroccio
Alfio Carroccio
Left subclavian artery (LSA) revascularization in thoracic endovascular aortic repair (TEVAR) remains controversial. Left subclavian artery coverage without revascularization can cause stroke and death. TEVAR has gained popularity for the treatment of chronic type B aortic dissection (cTBD). Using the Vascular Quality Initiative (VQI) database, we reviewed outcomes of LSA revascularization in TEVAR for cTBD. The VQI registry identified 5683 patients treated with TEVAR from July 2010 to July 2016, including 208 repairs for cTBD. We analyzed outcomes per the Society for Vascular Surgery reporting standards. Of the 208 patients, 150 (72.1%) were male with a median age of 65.0 years (interquartile range [IQR], 55.0-72.0). Median aneurysm diameter was 5.7 cm (IQR, 5.0-6.5 cm). Data on the patency of the LSA was available in 131 (63.0%) patients. Twenty-five (19.1%) had occlusion of the LSA without revascularization, while 106 (80.9%) maintained patency or had revascularization. Successful device delivery occurred in all 131 (100%) patients. Maintaining LSA patency did not affect the rate of cerebrovascular accident (P = .16), spinal cord ischemia (P = 1.00), or death (P = 1.00). This was also nonsignificant when analyzing the subgroup of 98 elective cases. There was no difference in the rates of endoleak. Any intervention for the LSA (revascularization or occlusion) led to a longer procedure time (203.6 minutes vs 163.7 minutes, P = .04). Maintaining LSA patency during TEVAR for cTBD offers no advantage in perioperative morbidity or endoleak. Occlusion of LSA may be performed safely in this cohort and revascularization reserved for those who have anatomy that compromises perfusion to critical organs.

1 April 2021 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
KQKhalil Qato
Khalil Qato
NNNhan Nguyen
Nhan Nguyen
VBVasilieos Bouris
Vasilieos Bouris
ACAllan Conway
Allan Conway
CEClinton Ehidom
Clinton Ehidom
ACAlfio Carroccio
Alfio Carroccio

1 July 2015 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
ARAditya Rachakonda
Aditya Rachakonda
KQKhalil Qato
Khalil Qato
TKTamim Khaddash
Tamim Khaddash
ACAlfio Carroccio
Alfio Carroccio
VPVicken Pamoukian
Vicken Pamoukian
GGGary Giangola
Gary Giangola